Reply to K.J. Van Zee et al

Journal of Clinical Oncology

Volumn 30, Issue 25, 2012, Pages 3144-3145

  Yi, Min ^a   Meric Bernstam, Funda ^a   Kuerer, Henry M ^a   Mittendorf, Elizabeth A ^a   Bedrosian, Isabelle ^a   Lucci, Anthony ^a   Hwang, Rosa F ^a   Crow, Jaime R ^a   Luo, Sheng ^b   Hunt, Kelly K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CALIBRATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LETTER; NOMOGRAM; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE RISK; SAMPLE SIZE; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 84865753982     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.9406     Document Type: Letter

References (8)

1. Van Zee KJ, Patil S: Validation of a nomogram for predicting risk of local recurrence for ductal carcinoma in situ. J Clin Oncol 30:3143-3144, 2012
2. Yi M, Meric-Bernstam F, Kuerer HM, et al: Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30:600-607, 2012
3. Rudloff U, Jacks LM, Goldberg JI, et al: Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol 28:3762-3769, 2010
4. Hosmer D, Lemeshow S: Applied Logistic Regression (ed 2). New York, NY, Wiley, 2000, pp 162
5. EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group, Bijker N, et al: Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387, 2006
6. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998
7. Silverstein MJ, Lagios MD: Choosing treatment for patients with ductal carcinoma in situ: Fine tuning the University of Southern California/Van Nuys Prognostic Index. J Natl Cancer Inst Monogr 2010:193-196, 2010
8. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267-2274, 1996